These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19052333)

  • 1. Metabolic syndrome & psychiatric disorders.
    Singh SM; Mattoo SK
    Indian J Med Res; 2008 Sep; 128(3):237-45. PubMed ID: 19052333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of psychiatric symptoms associated with neurosyphilis.
    Sanchez FM; Zisselman MH
    Psychosomatics; 2007; 48(5):440-5. PubMed ID: 17878505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in severe mental disorders.
    Ohaeri JU; Akanji AO
    Metab Syndr Relat Disord; 2011 Apr; 9(2):91-8. PubMed ID: 20964513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic medications and HIV.
    Thompson A; Silverman B; Dzeng L; Treisman G
    Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and psychotropic medications.
    Filaković P; Petek Erić A; Radanović-Grgurić L
    Med Glas (Zenica); 2012 Aug; 9(2):180-8. PubMed ID: 22926348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and mental illness.
    Newcomer JW
    Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Swedish clinical guidelines--prevention and management of metabolic risk in patients with severe psychiatric disorders.
    Gothefors D; Adolfsson R; Attvall S; Erlinge D; Jarbin H; Lindström K; von Hausswolff-Juhlin YL; Morgell R; Toft E; Osby U;
    Nord J Psychiatry; 2010 Oct; 64(5):294-302. PubMed ID: 20662682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of psychotropic medications in children with developmental disabilities.
    Calles JL
    Pediatr Clin North Am; 2008 Oct; 55(5):1227-40, ix. PubMed ID: 18929062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving drug safety and tolerability in psychiatric clinical practice.
    Haddad PM; Dursun SM
    Hum Psychopharmacol; 2008 Jan; 23 Suppl 1():S1-2. PubMed ID: 18098219
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].
    Lazzeretti L; Pracucci C; Benni L; Godini L; Talamba GA; Faravelli C
    Riv Psichiatr; 2011; 46(1):1-17. PubMed ID: 21446107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating and managing common psychiatric comorbidities seen in chronic pain patients.
    Kirsh KL
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):39-47. PubMed ID: 20345199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV & psychiatric disorders.
    Chandra PS; Desai G; Ranjan S
    Indian J Med Res; 2005 Apr; 121(4):451-67. PubMed ID: 15817956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic drug use in relation to psychiatric symptoms in community-living persons with Alzheimer's disease.
    Semla TP; Cohen D; Freels S; Paveza GJ; Ashford JW; Gorelick P; Luchins D; Eisdorfer C
    Pharmacotherapy; 1995; 15(4):495-501. PubMed ID: 7479203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychiatric considerations in patients with decreased levels of consciousness.
    Young JL; Rund D
    Emerg Med Clin North Am; 2010 Aug; 28(3):595-609. PubMed ID: 20709245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India.
    Mattoo SK; Singh SM
    Indian J Med Res; 2010 Jan; 131():46-52. PubMed ID: 20167973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gynecological management of climacteric syndrome with psychiatric disorders].
    Akamatsu T; Ohtsuki K; Akiyama T; Saito H; Yanaihara T; Kimura T; Hayakawa T; Tomiyama M; Kamei Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Sep; 48(9):806-12. PubMed ID: 8841047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension, insulin resistance, and the metabolic syndrome.
    Natali A; Ferrannini E
    Endocrinol Metab Clin North Am; 2004 Jun; 33(2):417-29. PubMed ID: 15158527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychopharmacologic therapies in dermatology: an update.
    Lee CS; Koo J
    Dermatol Clin; 2005 Oct; 23(4):735-44. PubMed ID: 16112451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.